Robert Koch Award 2015, together with Charles M. Rice
Clausthal-Zellerfeld Prize 2000
The Robert Koch laureate Professor Ralf Bartenschlager is Executive Director of the Department of Molecular Virology at the University of Heidelberg, Germany. At the same time, Bartenschlager is head of the infection and cancer program at the German Cancer Research Center (DKFZ) in Heidelberg. The second laureate, Dr. Charles M. Rice, is Scientific and Executive Director of the interdisciplinary “Center for the Study of Hepatitis C” at The Rockefeller University, New York, USA. Both laureates are credited with helping to understand the HCV lifecycle, identifying promising antiviral targets, and establishing reproducible cell culture systems for basic studies that could also be used for drug screening and testing.
In chronic cases, HCV infection can result in liver cirrhosis and cancer. With new treatment options catalyzed by these basic discoveries, it is now possible to eliminate the virus permanently in the vast majority of patients treated. Worldwide, approximately 170 million people are infected with HCV, including an estimated 400,000 to 500,000 people in Germany.